| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.046 | 0.6 |